CLINICAL_TRIALS
trial_result
· 2017-10-13
Clinical Trial Update: RDEA3170 Bioavailability Study [Phase 1]
Summary
The update notes completion and results posting of a Phase 1 bioavailability study of RDEA3170 for gout.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ardea Biosciences, Inc. | Conditions: Gout | Phase 1 | Status: COMPLETED | Results posted: 2017-10-13